2020
DOI: 10.3389/fchem.2020.00343
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Based Virtual Screening: From Classical to Artificial Intelligence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
239
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 408 publications
(280 citation statements)
references
References 143 publications
(169 reference statements)
0
239
0
2
Order By: Relevance
“…Virtual screening and de novo drug designing approaches are effective tools to identify novel hit molecules with desired biological activity [121,122]. Analyzing the interaction between macromolecules and small ligands is an effective way to simplify the path of modern drug discovery [75], which also minimize the time and cost for drug development process [123].…”
Section: Discussionmentioning
confidence: 99%
“…Virtual screening and de novo drug designing approaches are effective tools to identify novel hit molecules with desired biological activity [121,122]. Analyzing the interaction between macromolecules and small ligands is an effective way to simplify the path of modern drug discovery [75], which also minimize the time and cost for drug development process [123].…”
Section: Discussionmentioning
confidence: 99%
“…Autodock Vina was the software used to perform the virtual search of OliveNet™ secoiridoids (Trott and Olson, 2010 ). The virtual search utilized a target-based docking to the structural and non-structural proteins of the virus (Maia et al, 2020 ). In this study, the drug targets were mainly the SARS-CoV-2 S protein, a structural protein, and M pro , a non-structural protein.…”
Section: Methodsmentioning
confidence: 99%
“…Recent advances in structural bioinformatics and virtual screening approaches have revolutionized the identification and/or repurposing of marketed drugs or bioactive compounds for effective treatment of various human diseases, including infectious diseases (Chang et al., 2016 ; Gioia et al., 2017 ; Kitchen et al., 2004 ; Lasko et al., 2017; Maia et al., 2020 ; Pinzi & Rastelli, 2019 ; Slater & Kontoyianni, 2019 ). Moreover, in silico approaches, including molecular dynamics (MD), have also been widely used to determine the conformational space of the investigated targets, ligands, and ligand-target complexes, and thus better understand the dynamic behavior of ligand-target complexes (Bhardwaj & Purohit, 2020 ; Pinzi & Rastelli, 2019 ; Rajendran et al., 2018 ; Slater & Kontoyianni, 2019 ; Śledź & Caflisch, 2018).…”
Section: Introductionmentioning
confidence: 99%